CBIC Infection Control CIC New Questions

The correct answer is D, "Hepatitis B immune globulin (HBIG) and hepatitis B vaccine," as this is the recommended regimen for an HBsAb-negative employee with a percutaneous exposure to blood from an HBsAg-positive patient. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), post-exposure prophylaxis (PEP) for hepatitis B virus (HBV) exposure depends on the employee’s vaccination status and the source’s HBsAg status. For an unvaccinated or known HBsAb-negative individual (indicating no immunity) exposed to HBsAg-positive blood, the standard PEP includes both HBIG and the hepatitis B vaccine. HBIG provides immediate passive immunity by delivering pre-formed antibodies, while the vaccine initiates active immunity to prevent future infections (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents). The HBIG should be administered within 24 hours of exposure (preferably within 7 days), and the first dose of the vaccine should be given concurrently, followed by the complete vaccine series.

Option A (immune serum globulin and hepatitis B vaccine) is incorrect because immune serum globulin (ISG) is a general immunoglobulin preparation and not specific for HBV; HBIG, which contains high titers of anti-HBs, is the appropriate specific immunoglobulin for HBV exposure. Option B (hepatitis B immune globulin [HBIG] alone) is insufficient, as it provides only temporary passive immunity without initiating long-term active immunity through vaccination, which is critical for an unvaccinated individual. Option C (hepatitis B vaccine alone) is inadequate for immediate post-exposure protection, as it takes weeks to develop immunity, leaving the employee vulnerable in the interim.

The recommendation for HBIG and hepatitis B vaccine aligns with CBIC’s emphasis on evidence-based post-exposure management to prevent HBV transmission in healthcare settings (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This dual approach is supported by CDC guidelines, which prioritize rapid intervention to reduce the risk of seroconversion following percutaneous exposure (CDC Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV, 2013).

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies nontuberculous mycobacteria (NTM), including Mycobacterium fortuitum, as organisms commonly associated with water sources, particularly potable water systems. An unusual increase in M. fortuitum–positive bronchoscopy cultures is most often linked to waterborne contamination during endoscope reprocessing, making rinsing with tap water the most likely cause.

Tap water is not sterile and may harbor NTM, which are resistant to standard municipal water treatment and capable of forming biofilms within plumbing systems. If bronchoscopes are rinsed with tap water after high-level disinfection and not followed by appropriate sterile or filtered water rinses and thorough drying, organisms such as M. fortuitum may contaminate internal channels. This can lead to pseudo-outbreaks, where cultures are positive due to contamination rather than true patient infection.

Option B, inadequate cleaning prior to disinfection, can contribute to overall reprocessing failure but is less specifically associated with NTM contamination patterns. Option A is unlikely, as sporicidal solutions are effective disinfectants. Option D, drying with air or alcohol, is a recommended step to reduce microbial growth and would not cause contamination.

For CIC® exam preparation, recognizing that tap water exposure during endoscope reprocessing is a classic source of nontuberculous mycobacteria contamination is a key concept in outbreak investigation and device reprocessing surveillance.

The incidence rate is calculated using the formula:

Why the Other Options Are Incorrect?

B. (30 ÷ 150,000) × 100 = X – Incorrect multiplier (should be 100,000 for standard incidence rate).

C. (115 ÷ 150,000) × 100,000 = X – 115 represents total cases (prevalence), not incidence.

D. (115 ÷ 100,000) × 100 = X – Uses the wrong denominator and multiplier.

CBIC Infection Control Reference

APIC defines the incidence rate as the number of new cases per population unit, typically per 100,000 people​.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that the most important criterion when selecting a disinfectant is the intended purpose for which it will be used. Disinfectants must be chosen based on the type of surface or item, the level of microbial kill required, and the risk of infection associated with the use of that item. This approach aligns with Spaulding’s classification system, which categorizes items as critical, semi-critical, or noncritical and guides the required level of disinfection or sterilization.

Understanding the purpose of the disinfectant ensures that the selected product is effective against the appropriate microorganisms and suitable for the clinical application, whether it involves environmental surfaces, noncritical patient care equipment, or semi-critical devices. For example, a low-level disinfectant may be sufficient for noncritical items, whereas high-level disinfection is required for semi-critical devices. Selecting a disinfectant without first defining its purpose can result in ineffective infection prevention or unnecessary exposure to harsh chemicals.

Option A is incorrect because disinfectants are not intended for use on living tissue; antiseptics serve that role. Option C is secondary—while active ingredients matter, they are evaluated after determining intended use. Option D is important for safety and regulatory compliance but does not drive appropriateness of clinical application.

For the CIC® exam, recognizing that intended use is the foundational decision point in disinfectant selection is essential for evidence-based infection prevention practice.